BAT Delays Launch of Synthetic Nicotine E-cigarette to Q4.

Aug.27.2024
BAT Delays Launch of Synthetic Nicotine E-cigarette to Q4.
British American Tobacco (BAT) delays synthetic nicotine e-cigarette launch to fourth quarter due to production issues, still plans release.

According to a report by N.News on August 27, British American Tobacco (BAT) has decided to postpone the release of its synthetic nicotine e-cigarette to the fourth quarter.


Despite some delays compared to the initial plan, the company still plans to launch this product in the fourth quarter.


BAT's South Korean subsidiary, LFMT, revealed that BAT originally planned to launch a synthetic nicotine e-cigarette in the third quarter, but due to production preparation issues, the release schedule has been postponed.


However, the company still maintains that despite some delays, the product will still be launched in the fourth quarter.


A representative of the company stated that,


The planned launch of the synthetic nicotine e-cigarette by BAT in the domestic market remains unchanged. Despite delays in release due to production preparations, the product is set to be launched in the fourth quarter.


In May of this year (2024), BAT announced that it would be launching a new product, a synthetic nicotine e-cigarette, in South Korea. The company also revealed that it plans to pass on the savings from tax incentives to consumers.


In July last year (2023), the company launched "Vuse" with natural nicotine e-liquid in the South Korean market, but it faced tough competition compared to synthetic nicotine e-cigarettes that do not require payment of tobacco tax.


Currently, South Korea's Tobacco Business Act only defines products made from tobacco leaves as tobacco products, which means that synthetic nicotine e-cigarettes are not legally restricted.


Synthetic nicotine e-cigarettes are cheap and law enforcement and penalties cannot be carried out in smoke-free areas. They can even be sold near schools with a lack of relevant legal constraints. In addition, these products can be freely sold online, with unrestricted advertising marketing, making it easy for teenagers to be influenced. Although the South Korean government is conducting research on synthetic nicotine e-cigarettes and proposing relevant regulatory legislation in parliament, progress is slow.


As a result, BAT has announced the formal launch of a synthetic nicotine e-cigarette, which will further intensify market competition.


An industry professional pointed out:


For BAT, which is making inroads into the e-cigarette market, synthetically produced nicotine e-cigarettes without any regulation undoubtedly have a relative advantage. Therefore, unless the government and Congress refine relevant regulations, this trend will continue.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia’s NSW Finds Lower Vaping Rates Among Teenagers Aged 14 to 17
Australia’s NSW Finds Lower Vaping Rates Among Teenagers Aged 14 to 17
A new report from Cancer Council’s Generation Vape research project shows that fewer teenagers in New South Wales are trying vaping after the state government introduced tougher vaping goods laws. Among surveyed NSW teenagers aged 14 to 17, the proportion who had tried vaping fell from 29.6% in April 2024 to 20.1% in October 2025.
Mar.17 by 2FIRSTS.ai
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s ANSES Report Reframes the Vape Debate: Harm Reduction Confirmed, Regulatory Barriers Rising
France’s top health agency has confirmed that vaping is less harmful than smoking — but not risk-free — reshaping the country’s regulatory trajectory. As Paris withdraws a proposed vape tax and debates stricter ingredient, emissions and youth-protection rules, the ANSES report signals not prohibition, but tighter technical oversight. For manufacturers, retailers and EU policymakers, France may be previewing Europe’s next phase of nicotine governance.
Special Report
Feb.23
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
China Tobacco Jiangsu IC appears to have developed a nicotine oral film product under the "Nanjing" brand, according to images circulating on Chinese social media. If confirmed, this could potentially mark China Tobacco's first oral nicotine product targeting the domestic market. The product's authenticity has not been officially verified, and no nicotine pouch products have been approved for sale in China.
Special Report
Feb.09
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao: What the Rise of Nicotine Pouches Means for Tobacco Retailers
Alan Zhao argues that nicotine pouches are no longer a niche alternative, but a force quietly reshaping the future of tobacco retail. For distributors and retailers, the real risk is not missing a trend—it is moving too late, after regulation tightens, shelf space hardens and the market begins to choose its winners.
Mar.31 by Alan Zhao | 2Firsts Perspectives
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24